Optimum modification for the highest cytotoxicity of cationized ribonuclease

被引:37
作者
Futami, J [1 ]
Nukui, E [1 ]
Maeda, T [1 ]
Kosaka, M [1 ]
Tada, H [1 ]
Seno, M [1 ]
Yamada, H [1 ]
机构
[1] Okayama Univ, Dept Biosci & Biotechnol, Fac Engn, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan
关键词
cationization; cytotoxicity; protein transduction; ribonuclease;
D O I
10.1093/oxfordjournals.jbchem.a003214
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cationization of a protein is considered to be a powerful strategy for internalizing a functional protein into cells. Cationized proteins appear to adsorb to the cell surface by electrostatic interactions, then enter the cell in a receptor- and transporter-independent fashion. Thus, in principle, all cell types appear to take up cationized proteins. Since ribonucleases (RNases) have a latent cytotoxic potential, cationized RNases could be useful cancer chemotherapeutics. In this study, we investigated the effect of the degree of cationization on the cytotoxicity of RNase A by modifying carboxyl groups with ethylenediamine. We found that there is an optimum degree of modification for cytotoxicity, in which 5 to 7 out of 11 carboxyl groups in RNase A are modified, toward MCF-7 and 3T3-SV-40 cells. More interestingly, the cytotoxicity of cationized RNase As correlates well with the value of [RNase activity] x [estimated concentration of RNase free from RNase inhibitor], mimicking the practical enzymatic activity of cationized RNase As in cytosol. The results indicate that cationization of a protein to an optimum level is important for maintaining protein function in the cytosol. Sophisticated protein cationization techniques will help to advance protein transduction technology.
引用
收藏
页码:223 / 228
页数:6
相关论文
共 56 条
  • [1] APPLE RJ, 1988, J IMMUNOL, V140, P3290
  • [2] ARDELT W, 1991, J BIOL CHEM, V266, P245
  • [3] Protein therapy - delivery guaranteed
    Bayley, H
    [J]. NATURE BIOTECHNOLOGY, 1999, 17 (11) : 1066 - +
  • [4] BLACKBURN P, 1977, J BIOL CHEM, V252, P5904
  • [5] REFINEMENT OF THE STRUCTURE OF BOVINE SEMINAL RIBONUCLEASE
    CAPASSO, S
    GIORDANO, F
    MATTIA, CA
    MAZZARELLA, L
    ZAGARI, A
    [J]. BIOPOLYMERS, 1983, 22 (01) : 327 - 332
  • [6] Carroll SS, 1996, J BIOL CHEM, V271, P4988
  • [7] A gender-specific mRNA encoding a cytotoxic ribonuclease contains a 3′ UTR of unusual length and structure
    Chen, SL
    Le, SY
    Newton, DL
    Maizel, JV
    Rybak, SM
    [J]. NUCLEIC ACIDS RESEARCH, 2000, 28 (12) : 2375 - 2382
  • [8] Design, characterization and anti-tumour cytotoxicity of a panel of recombinant, mammalian ribonuclease-based immunotoxins
    Deonarain, MP
    Epenetos, AA
    [J]. BRITISH JOURNAL OF CANCER, 1998, 77 (04) : 537 - 546
  • [9] Arginine-rich peptides - An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery
    Futaki, S
    Suzuki, T
    Ohashi, W
    Yagami, T
    Tanaka, S
    Ueda, K
    Sugiura, Y
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (08) : 5836 - 5840
  • [10] Tissue-specific expression of pancreatic-type RNases and RNase inhibitor in humans
    Futami, J
    Tsushima, Y
    Murato, Y
    Tada, H
    Sasaki, J
    Seno, M
    Yamada, H
    [J]. DNA AND CELL BIOLOGY, 1997, 16 (04) : 413 - 419